Buyean Lee1, Stefan Tiefenbacher2, Donna M Platt2, Roger D Spealman2. 1. New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Box 9102, Southborough, MA 01772-9102, USA. buyean_lee@hms.harvard.edu. 2. New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Box 9102, Southborough, MA 01772-9102, USA.
Abstract
RATIONALE: Stress has been suggested to play a role in relapse to cocaine-seeking behavior. An important physiological system activated by stress is the hypothalamic-pituitary-adrenal (HPA) axis; however, evidence for a role of HPA axis activation in cocaine relapse has been contradictory. OBJECTIVES: This study examined the effects of pharmacological stimulation of the HPA axis on reinstatement of drug-seeking behavior and salivary cortisol levels in a non-human primate model of cocaine relapse. In addition, the effect of corticotropin releasing hormone type 1 receptor (CRH-R1) blockade on cocaine priming-induced reinstatement was investigated. METHODS: Squirrel monkeys were trained to self-administer cocaine under a second-order schedule in which behavior was maintained by IV drug injections and a drug-paired visual stimulus. A period of extinction was then imposed during which saline was substituted for cocaine and the stimulus was omitted. Subsequently, monkeys were tested for reinstatement of cocaine seeking following priming injections of drugs. During reinstatement tests, the drug-paired stimulus was restored. Salivary cortisol levels were determined to measure the effects of drug treatments on the HPA axis activity. RESULTS: Priming with corticotropin releasing hormone (10 and 50 microg/kg), adrenocorticotropic hormone (1 microg/kg), or cortisol (1-10 mg/kg) did not induce significant reinstatement of cocaine seeking. All of these treatments, however, resulted in a significant increase in salivary cortisol. In contrast, priming injections of cocaine (0.1-1.0 mg/kg) dose-dependently induced reinstatement of drug seeking, but did not increase salivary cortisol. The CRH-R1 antagonist CP-154,526 (10 mg/kg, IV) did not modulate cocaine priming-induced reinstatement of drug seeking, but attenuated CRH-induced increases in salivary cortisol. CONCLUSIONS: The results suggest that activation of the HPA axis is neither necessary nor sufficient for reinstatement of cocaine-seeking behavior in this non-human primate model of cocaine relapse.
RATIONALE: Stress has been suggested to play a role in relapse to cocaine-seeking behavior. An important physiological system activated by stress is the hypothalamic-pituitary-adrenal (HPA) axis; however, evidence for a role of HPA axis activation in cocaine relapse has been contradictory. OBJECTIVES: This study examined the effects of pharmacological stimulation of the HPA axis on reinstatement of drug-seeking behavior and salivary cortisol levels in a non-human primate model of cocaine relapse. In addition, the effect of corticotropin releasing hormone type 1 receptor (CRH-R1) blockade on cocaine priming-induced reinstatement was investigated. METHODS: Squirrel monkeys were trained to self-administer cocaine under a second-order schedule in which behavior was maintained by IV drug injections and a drug-paired visual stimulus. A period of extinction was then imposed during which saline was substituted for cocaine and the stimulus was omitted. Subsequently, monkeys were tested for reinstatement of cocaine seeking following priming injections of drugs. During reinstatement tests, the drug-paired stimulus was restored. Salivary cortisol levels were determined to measure the effects of drug treatments on the HPA axis activity. RESULTS: Priming with corticotropin releasing hormone (10 and 50 microg/kg), adrenocorticotropic hormone (1 microg/kg), or cortisol (1-10 mg/kg) did not induce significant reinstatement of cocaine seeking. All of these treatments, however, resulted in a significant increase in salivary cortisol. In contrast, priming injections of cocaine (0.1-1.0 mg/kg) dose-dependently induced reinstatement of drug seeking, but did not increase salivary cortisol. The CRH-R1 antagonist CP-154,526 (10 mg/kg, IV) did not modulate cocaine priming-induced reinstatement of drug seeking, but attenuated CRH-induced increases in salivary cortisol. CONCLUSIONS: The results suggest that activation of the HPA axis is neither necessary nor sufficient for reinstatement of cocaine-seeking behavior in this non-human primate model of cocaine relapse.
Authors: J M Fahey; G A Pritchard; L L Moltke; J S Pratt; J M Grassi; R I Shader; D J Greenblatt Journal: J Pharmacol Exp Ther Date: 1998-04 Impact factor: 4.030
Authors: Richard De La Garza; Liza H Ashbrook; Sarah E Evans; Caitlin A Jacobsen; Ari D Kalechstein; Thomas F Newton Journal: Am J Addict Date: 2009 Nov-Dec
Authors: Evan N Graf; Michael A Hoks; Jean Baumgardner; Jose Sierra; Oliver Vranjkovic; Colin Bohr; David A Baker; John R Mantsch Journal: Neuropsychopharmacology Date: 2011-03-16 Impact factor: 7.853
Authors: John R Mantsch; David A Baker; David M Francis; Eric S Katz; Michael A Hoks; Joseph P Serge Journal: Psychopharmacology (Berl) Date: 2007-09-26 Impact factor: 4.530
Authors: Evan N Graf; Robert A Wheeler; David A Baker; Amanda L Ebben; Jonathan E Hill; Jayme R McReynolds; Mykel A Robble; Oliver Vranjkovic; Daniel S Wheeler; John R Mantsch; Paul J Gasser Journal: J Neurosci Date: 2013-07-17 Impact factor: 6.167
Authors: John R Mantsch; William E Cullinan; Lee C Tang; David A Baker; Eric S Katz; Michael A Hoks; Dana R Ziegler Journal: Brain Res Date: 2007-07-14 Impact factor: 3.252
Authors: Daniel S Wheeler; Amanda L Ebben; Beliz Kurtoglu; Marissa E Lovell; Austin T Bohn; Isabella A Jasek; David A Baker; John R Mantsch; Paul J Gasser; Robert A Wheeler Journal: Eur J Neurosci Date: 2017-11-06 Impact factor: 3.386